Volume 8, Number 4—April 2002
Multiply Resistant (MR) Salmonella enterica Serotype Typhimurium DT 12 and DT 120: A Case of MR DT 104 in Disguise?
Multiresistant Salmonella enterica serotype Typhimurium definitive phage type (DT) 12 and DT 120 are more closely related to DT 104 than to non-multiresistant strains of their respective phage types. Multiresistant DT 12 and DT 120 appear to have arisen due to changes in phage susceptibility of DT 104 rather than horizontal transfer of resistance genes.
Multiresistant (MR) Salmonella enterica serovar Typhimurium definitive phage type (DT) 104 is now acknowledged as an internationally distributed zoonotic pathogen. Since 1991, this phage type has been second only to S. Enteritidis phage type 4 as the principal agent of human salmonellosis in England and Wales (1). MR DT 104 is characterized by resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracyclines (R-type ACSSuT). In MR DT 104 these antibiotic resistance genes have been accumulated in chromosomally encoded gene cassettes, a process mediated by the presence of class 1 integrons (2). Some isolates possess additional plasmid-mediated resistance to trimethoprim and low-level resistance to ciprofloxacin because of point mutations in the gyrA gene (1).
The potential exists for the horizontal transfer of genetic elements such as antibiotic resistance gene cassettes between Salmonella serotypes and phage types. Evidence of this transfer was reported in 2000, when the presence of an MR DT 104-like antibiotic resistance gene cluster was reported in S. Agona (3). Throughout the 1990s, the ACSSuT R-type was also identified in isolates of S. Typhimurium DT 12 and DT 120, although as yet numbers remain relatively small (27 of 84 and 22 of 109 of DT 12 and DT 120 isolates, respectively, were of R-type ACSSuT of a total of 2,651 S. Typhimurium isolates received at the Central Public Health Laboratory, London, in 2000). ACSSuT-resistant MR DT 12 incidence has remained fairly constant since the mid-1990s, but as isolations of sensitive DT 12 have diminished the relative proportion of MR DT 12 has increased (Figure 1). ACSSuT-resistant DT 120 has attained levels comparable with those of MR DT 12 only in the last few years but might well have been the predominant representative of DT 120, were it not for a large outbreak of antimicrobial-sensitive DT 120 in northern England during 1999-2000 (Figure 1) (4).
We investigated multiple antibiotic-resistant strains of MR DT 12 and MR DT 120 to determine if horizontal transfer of the antibiotic resistance genes had occurred between apparently unrelated phage types of S. Typhimurium.
Isolates of S. Typhimurium DT 12 and DT 120 from human, animal, food, and environmental sources received by the Laboratory of Enteric Pathogens from 1991 to 2000 were examined. For each phage type, 40 strains were selected, consisting of 15 antibiotic-sensitive strains, 12 strains of R-type ACSSuT, and 13 strains with non-ACSSuT R-types. Control strains of S. Typhimurium DT 104, both sensitive and MR, were also included.
All strains were characterized by phage type, in accordance with the scheme of Anderson et al. (5); antimicrobial susceptibility patterns were determined by using the breakpoint method (6), so that final concentrations (mg/mL-1) were ampicillin, 8; chloramphenicol, 8; furazolidone (Fu), 8; gentamicin (G), 4; kanamycin (K), 8; neomycin (Ne), 8; streptomycin, 16; sulfonamides, 64; tetracyclines, 8; trimethoprim, 2; and ciprofloxacin, 0.125.
The presence of the 13 kbp ACSSuT resistance gene cluster was determined by a long-polymerase chain reaction (PCR) method developed by Walker et al. (7) that amplified the 10- kbp region between the aadA2 (streptomycin resistance) and bla CARB-2 (ampicillin resistance) genes on the sequence of the antibiotic resistance gene cluster from S. Typhimurium DT 104 isolate H3380 (8). All strains of MR DT 104, DT 12, and DT 120 of R-type ACSSuT produced 10-kbp PCR amplicons; strains with other resistance patterns were negative.
The strains were examined for the presence of class 1 integrons by using a specific PCR assay (9). All strains of MR DT 104, DT 12, and DT 120 of R-type ACSSuT produced bands of 1.0 kbp and 1.2 kbp corresponding to the two integrons reported within the resistance gene cassettes (8,10). This corroborated the long-PCR result and demonstrated that there was no apparent variation in the arrangement of the genes within the ACSSuT resistance cassettes. Sensitive and non-ACSSuT-resistant strains were either negative by the class 1 integron PCR or produced bands other than 1.0 kbp and 1.2 kbp.
Pulsed-field gel electrophoresis (PFGE) analysis was performed by using the restriction enzyme XbaI according to the method of Powell et al. (11). Analysis showed that all sensitive and non-ACSSuT-resistant strains of DT 12 and DT 120 examined formed distinct groups of phage type-related PFGE profiles that clustered when analyzed by the nearest neighbor algorithm (12) (Figure 2). Nine distinct profiles (z1 to z9) were obtained from non-ACSSuT-resistant DT 12 and five different profiles (A to E) from the non-ACSSuT-resistant DT 120. Importantly, the ACSSuT-resistant strains of both DT 12 and DT 120 produced similar PFGE patterns that were distinct from those obtained by non-ACSSuT-resistant strains of the same phage type. However, these patterns were identical to those commonly observed in both sensitive and MR strains of DT 104 (profiles xtm1, xtm9, and xtm12). In contrast, the PFGE profiles of sensitive and ACSSuT-resistant strains of DT 104 typically differ by no more than a few bands. The PFGE profile of the ACSSuT-resistant DT 12 strains were all identical to that produced by most (80%- 90%) DT 104 isolates, termed profile xtm1 (10). The ACSSuT-resistant strains of DT 120 were mainly (8 of 12 strains) profile xtm1; the remainder were profiles xtm12 (3 of 12) and xtm9 (1 of 12). PFGE profiles xtm9 and xtm12 are less common variants of the basic xtm 1 pattern in DT 104. These variants occur in <5% of isolates and differ from the predominant pattern by two bands and one band, respectively (A. J. Lawson, unpub. data) (Figure 2).
Strains were analyzed for presence of plasmids by standard methods (13). All DT 104 and DT 12 strains contained a 90-kbp “serotype-specific” plasmid commonly found in S. Typhimurium (14). However, in DT 120 only those strains of R-type ACSSuT possessed this plasmid. Purified 90-kbp plasmid extracts from R-type ACSSuT strains of DT12, DT120, and DT104 were negative for integron-associated resistance gene cassettes by PCR (as described above), confirming the chromosomal location of the antibiotic resistance genes.
Strains of S. Typhimurium DT 12 and DT 120 of R-type ACSSuT possess antibiotic resistance gene cassettes indistinguishable from those typically present in multiresistant strains of the internationally distributed zoonotic pathogen S. Typhimurium DT 104. Strains of MR DT 12 and MR DT 120 of R-type ACSSuT have PFGE profiles distinct from those of other strains of the same phage type. Furthermore, the PFGE profiles of ACSSuT-resistant MR DT 12 and MR DT 120 are identical to those previously reported in MR DT 104. Additionally, ACSSuT-resistant strains of MR DT 120 possess a 90-kbp plasmid absent in DT 120 strains of other R-types, but present in DT 12 and DT 104 strains.
These data suggest that the occurrence of R-type ACSSuT in S. Typhimurium DT 12 and DT 120 strains is probably due to changes in phage susceptibility in a small proportion of MR DT 104 strains rather than to horizontal transfer of a resistance gene cassette. The Table shows selected phage reactions used in the S. Typhimurium phage typing scheme (5) and illustrates the similarity between the phage susceptibility profile of DT 12 and DT 120 and that of DT 104, especially the weaker reacting 104L profile. The causes of changes in phage susceptibility are complex and difficult to trace but are thought to result from the acquisition of new phages or plasmids and to changes in bacterial cell surface phage-receptors.
With regard to the international distribution of these strains, the ACSSuT-resistant DT 12 strains were all PFGE profile xtm1, and all originated from patients in England and Wales with no history of foreign travel. In contrast, the ACSSuT-resistant DT 120 strains consisted of a mixture of xtm1, xtm9, and xtm12 PFGE profiles and included cases from South Africa (xtm1), Sweden (xtm12), Northern Ireland (xtm9), and an isolate from a patient with a history of travel to the West Indies (xtm1). Continued surveillance coupled with molecular typing should be maintained to follow the spread of these new MR DT 104 variants in animals and humans.
Dr. Lawson is a clinical scientist in the Laboratory of Enteric Pathogens at the Central Public Health Laboratory, London. His research interests include the molecular detection and epidemiology of Salmonella, Campylobacter, and Helicobacter species, with particular reference to the emergence of resistance to antimicrobials in these bacteria.
We thank the staff of the Laboratory of Enteric Pathogens, Central Public Health Laboratory, London.
This study was partially funded by a grant (FS3114) from the Food Standards Agency, London, United Kingdom.
- Threlfall EJ. Epidemic Salmonella typhimurium DT 104-a truly international multiresistant clone. J Antimicrob Chemother. 2000;46:7–10.
- Tosini F, Visca P, Luzzi I, Dionisi AM, Pezzella C, Petrucca A, Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium. Antimicrob Agents Chemother. 1998;42:3053–8.
- Cloeckaert A, Sidi Boumedine K, Flaujac G, Imberechts H, D'Hooghe I, Chaslus-Dancla E. Occurrence of a Salmonella enterica serovar typhimurium DT 104-like antibiotic resistance gene cluster including the floR gene in S. enterica serovar agona. Antimicrob Agents Chemother. 2000;44:1359–61.
- Threlfall EJ, Ward LR, Skinner JA, Graham A. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar. Microb Drug Resist. 2000;6:319–25.
- Anderson ES, Ward LR, Saxe MJ, de Sa JD. Bacteriophage-typing designations of Salmonella typhimurium. J Hyg (Lond). 1977;78:297–300.
- Frost JA. Testing for resistance to antimicrobial drugs. In: Chart H, editor. Methods in practical laboratory bacteriology. Boca Raton (FL): CRC Press; 1994;73-82.
- Walker RA, Lindsay E, Woodward MJ, Ward LR, Threlfall EJ. Variation in clonality and antibiotic-resistance genes among multiresistant Salmonella enterica serotype typhimurium phage-type U302 (MR U302) from humans, animals, and foods. Microb Drug Resist. 2001;7:13–21.
- Briggs CE, Fratamico PM. Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT 104. Antimicrob Agents Chemother. 1999;43:846–9.
- Daly M, Fanning S. Characterization and chromosomal mapping of antimicrobial resistance genes in Salmonella enterica serotype Typhimurium. Appl Environ Microbiol. 2000;66:4842–8.
- Ridley A, Threlfall EJ. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb Drug Resist. 1998;4:113–8.
- Powell NG, Threlfall EJ, Chart H, Rowe B. Subdivision of Salmonella enteritidis PT4 by pulsed-field electrophoresis: potential for epidemiological surveillance. FEMS Microbiol Lett. 1994;119:193–8.
- Kovach WL. MVSP - A multivariate statistical package for Windows, ver 3.1. Pentraeth: Wales: Kovach Computing Services; 1999.
- Kado CI, Liu ST. Rapid procedure for detection of large and small plasmids. J Bacteriol. 1981;145:1365–73.
- Threlfall EJ, Hampton MD, Schofield SL, Ward LR, Frost JA, Rowe B. Epidemiological application of differentiating multiresistant Salmonella typhimurium DT 104 by plasmid profile. Commun Dis Rep. 1996;6:155–8.
Suggested Citation for this article: Lawson AJ, Dassama MU, Ward LR, Threlfall EJ. Multiply Resistant (MR) Salmonella enterica Serotype Typhimurium DT 12 and DT 120: A Case of MR DT 104 in Disguise? Emerg Infect Dis [serial on the Internet]. 2002, Apr [date cited]. http://dx.doi.org/10.3201/eid0804.010348
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: April 18, 2012
- Page last updated: April 18, 2012
- Page last reviewed: April 18, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)